BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 32378664)

  • 1. [Drug Development Based on Intracellular Pharmacokinetic Analysis of Molecular Target Drug in Mice Bearing Patient-derived Xenograft Model].
    Hamada A
    Yakugaku Zasshi; 2020; 140(5):641-648. PubMed ID: 32378664
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterizing the efficacy of cancer therapeutics in patient-derived xenograft models of metastatic breast cancer.
    Turner TH; Alzubi MA; Sohal SS; Olex AL; Dozmorov MG; Harrell JC
    Breast Cancer Res Treat; 2018 Jul; 170(2):221-234. PubMed ID: 29532339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Report of the use of patient-derived xenograft models in the development of anticancer drugs in Japan.
    Tsumura R; Koga Y; Hamada A; Kuwata T; Sasaki H; Doi T; Aikawa K; Ohashi A; Katano I; Ikarashi Y; Ito M; Ochiai A
    Cancer Sci; 2020 Sep; 111(9):3386-3394. PubMed ID: 32639672
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Applications of patient-derived tumor xenograft models and tumor organoids.
    Yoshida GJ
    J Hematol Oncol; 2020 Jan; 13(1):4. PubMed ID: 31910904
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Establishment of Gastric Cancer Patient-derived Xenograft Models and Primary Cell Lines.
    Lu JH; Wang Y; Meng Q; Zeng ZL
    J Vis Exp; 2019 Jul; (149):. PubMed ID: 31380849
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Establishment and characterization of a non-gestational choriocarcinoma patient-derived xenograft model.
    Oda Y; Niimi K; Yoshida K; Tamauchi S; Yokoi A; Yasui Y; Nishiko Y; Shibata M; Shimizu Y; Yoshihara M; Ikeda Y; Yoshikawa N; Nishino K; Yamamoto E; Kajiyama H
    BMC Cancer; 2023 Nov; 23(1):1103. PubMed ID: 37957624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patient-derived Heterogeneous Xenograft Model of Pancreatic Cancer Using Zebrafish Larvae as Hosts for Comparative Drug Assessment.
    Wang L; Chen H; Fei F; He X; Sun S; Lv K; Yu B; Long J; Wang X
    J Vis Exp; 2019 Apr; (146):. PubMed ID: 31107449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An original patient-derived xenograft of prostate cancer with cyst formation.
    Yoshikawa T; Kobori G; Goto T; Akamatsu S; Terada N; Kobayashi T; Tanaka Y; Jung G; Kamba T; Ogawa O; Inoue T
    Prostate; 2016 Aug; 76(11):994-1003. PubMed ID: 27098584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A 3D in vitro model of patient-derived prostate cancer xenograft for controlled interrogation of in vivo tumor-stromal interactions.
    Fong EL; Wan X; Yang J; Morgado M; Mikos AG; Harrington DA; Navone NM; Farach-Carson MC
    Biomaterials; 2016 Jan; 77():164-72. PubMed ID: 26599623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Application and development of patient-derived tumor xenograft model in translational medicine of tumor].
    Wang Z; Zhu Z
    Zhonghua Wei Chang Wai Ke Za Zhi; 2017 May; 20(5):596-600. PubMed ID: 28534338
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patient-Derived Xenograft Models in Breast Cancer Research.
    Na D; Moon HG
    Adv Exp Med Biol; 2021; 1187():283-301. PubMed ID: 33983584
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Establishment of a patient-derived xenograft model and cell line of malignant transformation of mature cystic teratoma of the ovary.
    Tamauchi S; Suzuki S; Xuboya C; Yoshihara M; Yoshida K; Ikeda Y; Yoshikawa N; Kajiyama H; Kikkawa F
    J Obstet Gynaecol Res; 2021 Feb; 47(2):713-719. PubMed ID: 33300248
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Movember GAP1 PDX project: An international collection of serially transplantable prostate cancer patient-derived xenograft (PDX) models.
    Navone NM; van Weerden WM; Vessella RL; Williams ED; Wang Y; Isaacs JT; Nguyen HM; Culig Z; van der Pluijm G; Rentsch CA; Marques RB; de Ridder CMA; Bubendorf L; Thalmann GN; Brennen WN; Santer FR; Moser PL; Shepherd P; Efstathiou E; Xue H; Lin D; Buijs J; Bosse T; Collins A; Maitland N; Buzza M; Kouspou M; Achtman A; Taylor RA; Risbridger G; Corey E
    Prostate; 2018 Dec; 78(16):1262-1282. PubMed ID: 30073676
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of immune responses to anti-PD-1 mono and combination immunotherapy in hematopoietic humanized mice implanted with tumor xenografts.
    Capasso A; Lang J; Pitts TM; Jordan KR; Lieu CH; Davis SL; Diamond JR; Kopetz S; Barbee J; Peterson J; Freed BM; Yacob BW; Bagby SM; Messersmith WA; Slansky JE; Pelanda R; Eckhardt SG
    J Immunother Cancer; 2019 Feb; 7(1):37. PubMed ID: 30736857
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advances in patient-derived tumor xenografts: from target identification to predicting clinical response rates in oncology.
    Rosfjord E; Lucas J; Li G; Gerber HP
    Biochem Pharmacol; 2014 Sep; 91(2):135-43. PubMed ID: 24950467
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current Update of Patient-Derived Xenograft Model for Translational Breast Cancer Research.
    Kawaguchi T; Foster BA; Young J; Takabe K
    J Mammary Gland Biol Neoplasia; 2017 Jun; 22(2):131-139. PubMed ID: 28451789
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel patient-derived orthotopic xenograft model of esophageal adenocarcinoma provides a platform for translational discoveries.
    Veeranki OL; Tong Z; Mejia A; Verma A; Katkhuda R; Bassett R; Kim TB; Wang J; Lang W; Mino B; Solis L; Kingsley C; Norton W; Tailor R; Wu JY; Krishnan S; Lin SH; Blum M; Hofstetter W; Ajani J; Kopetz S; Maru D
    Dis Model Mech; 2019 Dec; 12(12):. PubMed ID: 31732509
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patient-derived xenograft: a developing tool for screening biomarkers and potential therapeutic targets for human esophageal cancers.
    Lan T; Xue X; Dunmall LC; Miao J; Wang Y
    Aging (Albany NY); 2021 Apr; 13(8):12273-12293. PubMed ID: 33903283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Establishment of an orthotopic patient-derived xenograft mouse model using uveal melanoma hepatic metastasis.
    Kageyama K; Ohara M; Saito K; Ozaki S; Terai M; Mastrangelo MJ; Fortina P; Aplin AE; Sato T
    J Transl Med; 2017 Jun; 15(1):145. PubMed ID: 28645290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug resistance profiling of a new triple negative breast cancer patient-derived xenograft model.
    Matossian MD; Burks HE; Elliott S; Hoang VT; Bowles AC; Sabol RA; Wahba B; Anbalagan M; Rowan B; Abazeed ME; Bunnell BA; Moroz K; Miele L; Rhodes LV; Jones SD; Martin EC; Collins-Burow BM; Burow ME
    BMC Cancer; 2019 Mar; 19(1):205. PubMed ID: 30845999
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.